| A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood (NCT05979428) | Novo Nordisk A/S | 2023-08-07 |
| A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight (NCT05726227) | Novo Nordisk A/S | 2023-07-07 |
| A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy (NCT05872022) | Novo Nordisk A/S | 2023-07-05 |
| A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function (NCT05917938) | Novo Nordisk A/S | 2023-07-04 |
| A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5) (NCT05878938) | Novo Nordisk A/S | 2023-06-26 |
| A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease (NCT05891496) | Novo Nordisk A/S | 2023-06-20 |
| A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease (NCT05873660) | Novo Nordisk A/S | 2023-06-12 |
| Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3) (NCT05890976) | Novo Nordisk A/S | 2023-05-30 |
| A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese Men (NCT05870670) | Novo Nordisk A/S | 2023-05-15 |
| A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (NCT05636176) | Novo Nordisk A/S | 2023-05-08 |
| A Study to Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and Poland (NCT05795166) | Novo Nordisk A/S | 2023-04-27 |
| A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers (NCT05790681) | Novo Nordisk A/S | 2023-04-25 |
| A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healthy Participants (NCT05804162) | Novo Nordisk A/S | 2023-04-12 |
| A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9) (NCT05823948) | Novo Nordisk A/S | 2023-04-11 |
| A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the Body (NCT05564104) | Novo Nordisk A/S | 2023-04-05 |
| An Observational Study of Patients With Moderate Parkinson's Disease (NCT05779475) | Novo Nordisk A/S | 2023-04-05 |
| A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight (NCT05813925) | Novo Nordisk A/S | 2023-04-03 |
| Attitudes and Unmet Needs Among Type 2 Diabetes Patients (NCT05737810) | Novo Nordisk A/S | 2023-03-27 |
| A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Cardiologists (NCT05755373) | Novo Nordisk A/S | 2023-03-24 |
| Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey (NCT05765890) | Novo Nordisk A/S | 2023-03-24 |
| A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy Participants (NCT05784402) | Novo Nordisk A/S | 2023-03-16 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practice (NCT05443568) | Novo Nordisk A/S | 2023-03-09 |
| A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations (NCT05766709) | Novo Nordisk A/S | 2023-03-02 |
| REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels (NCT05669755) | Novo Nordisk A/S | 2023-03-01 |
| A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India (NCT05502562) | Novo Nordisk A/S | 2023-02-24 |
| DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy (NCT05755360) | Novo Nordisk A/S | 2023-02-21 |
| Persons With Obesity (PwO) Exploratory Research (NCT05736120) | Novo Nordisk A/S | 2023-02-19 |
| A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men (NCT05742919) | Novo Nordisk A/S | 2023-02-16 |
| A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-0499 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function (NCT05727644) | Novo Nordisk A/S | 2023-02-15 |
| A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (NCT05685238) | Novo Nordisk A/S | 2023-02-13 |
| A Research Study Looking Into Blood Levels of Three Different Formulations of the Study Medicine Ziltivekimab (NCT05721989) | Novo Nordisk A/S | 2023-02-03 |
| A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information (NCT05718570) | Novo Nordisk A/S | 2023-02-03 |
| A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9 (NCT05723835) | Novo Nordisk A/S | 2023-02-01 |
| A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight (NCT05394519) | Novo Nordisk A/S | 2023-02-01 |
| O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait (NCT05716724) | Novo Nordisk A/S | 2023-01-25 |
| A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America (NCT05579249) | Novo Nordisk A/S | 2023-01-19 |
| A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose (NCT05689099) | Novo Nordisk A/S | 2023-01-17 |
| A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight (NCT05649137) | Novo Nordisk A/S | 2023-01-04 |
| A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP) (NCT05646706) | Novo Nordisk A/S | 2023-01-04 |
| A Study to Compare the Blood Levels of Mim8 in Healthy Men When Administered With the DV3407-C1 Pen Injector or a Syringe and Cartridge (NCT05681845) | Novo Nordisk A/S | 2023-01-02 |
| Obesity and Cardiovascular Diseases, Cross-sectional Study in Saudi Arabia (NCT05642533) | Novo Nordisk A/S | 2022-12-31 |
| An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct (NCT05621746) | Novo Nordisk A/S | 2022-11-23 |
| First Human Dose Trial for a New Medication to Potentially Treat Liver Diseases (NCT05599945) | Novo Nordisk A/S | 2022-11-23 |
| A Study to Look at Safety and Tolerability of NNC0582-0001, How it is Transported Throughout the Body and How it Works in Healthy Adults (NCT05624580) | Novo Nordisk A/S | 2022-11-15 |
| A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight (NCT05567796) | Novo Nordisk A/S | 2022-11-01 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical Practice (NCT05443191) | Novo Nordisk A/S | 2022-10-20 |
| A Research Study, Looking at the Characterization of Treatment Intensified (Add on to Metformin) Real-world Adult Population With Type 2 Diabetes Mellitus in India, Pakistan and Thailand. (NCT05542420) | Novo Nordisk A/S | 2022-10-19 |
| Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range (NCT05564117) | Novo Nordisk A/S | 2022-10-11 |
| Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity (NCT05444153) | Novo Nordisk A/S | 2022-10-06 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (NCT05473286) | Novo Nordisk A/S | 2022-09-30 |
| Awareness, Care & Treatment In Obesity Management (NCT05690789) | Novo Nordisk A/S | 2022-09-27 |
| INSPIRE Turkey :A Research Study Looking at the Clinical Parameters Associated With Use and Discontinuation of Saxenda® in Local Clinical Practice in Turkey by Analysing Past Patient Medical Records (NCT05438186) | Novo Nordisk A/S | 2022-09-01 |
| A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE) (NCT05514535) | Novo Nordisk A/S | 2022-08-29 |
| A Research Study of a New Medicine NNC0113-6856 in Healthy Males (NCT05521256) | Novo Nordisk A/S | 2022-08-26 |
| Awareness, Care & Treatment In Obesity Management - An Observation in Mainland China (NCT05428501) | Novo Nordisk A/S | 2022-08-18 |
| Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity (NCT04998136) | Novo Nordisk A/S | 2022-08-15 |
| A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Men (NCT05498610) | Novo Nordisk A/S | 2022-08-11 |
| A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow (NCT05330325) | Novo Nordisk A/S | 2022-08-10 |
| A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight (NCT05486065) | Novo Nordisk A/S | 2022-08-08 |
| A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes (NCT05478252) | Novo Nordisk A/S | 2022-08-03 |
| A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis (NCT05442047) | Novo Nordisk A/S | 2022-08-02 |
| A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia (NCT05479591) | Novo Nordisk A/S | 2022-07-30 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice (NCT05443334) | Novo Nordisk A/S | 2022-07-28 |
| Research Study Investigating How Well NDec Works in People With Sickle Cell Disease (NCT05405114) | Novo Nordisk A/S | 2022-07-07 |
| A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE) (NCT05468632) | Novo Nordisk A/S | 2022-07-05 |
| A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Together (NCT05435677) | Novo Nordisk A/S | 2022-06-22 |
| A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet (NCT05429593) | Novo Nordisk A/S | 2022-06-22 |
| A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec (NCT05352815) | Novo Nordisk A/S | 2022-06-01 |
| A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and Inflammation (NCT05379829) | Novo Nordisk A/S | 2022-05-30 |
| A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B (NCT05365217) | Novo Nordisk A/S | 2022-05-18 |
| A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity (NCT05369390) | Novo Nordisk A/S | 2022-05-11 |
| Awareness, Care & Treatment In Obesity Management - An Observation in Asia Pacific (NCT05250427) | Novo Nordisk A/S | 2022-04-26 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practice (NCT05230589) | Novo Nordisk A/S | 2022-04-25 |
| Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes (NCT05533632) | Novo Nordisk A/S | 2022-04-25 |
| An International Chart Review and Survey for the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients With Type 2 Diabetes Across Countries in the Middle East and Africa (NCT05317845) | Novo Nordisk A/S | 2022-04-21 |
| A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes. (NCT05363774) | Novo Nordisk A/S | 2022-04-20 |
| A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation II (NCT05333107) | Novo Nordisk A/S | 2022-04-12 |
| A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2) (NCT05259033) | Novo Nordisk A/S | 2022-04-11 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice (NCT05316662) | Novo Nordisk A/S | 2022-04-06 |
| A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors (NCT05306418) | Novo Nordisk A/S | 2022-04-04 |
| A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice (NCT05230615) | Novo Nordisk A/S | 2022-04-01 |
| A Study Investigating the Safety and Performance of DV3395, a New Concept Device for the Delivery of Medicine. (NCT05314283) | Novo Nordisk A/S | 2022-03-28 |
| A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors (NCT05135559) | Novo Nordisk A/S | 2022-03-24 |
| Glycaemic Control and Other Clinical Parameters in Adult Type 2 Diabetes Patients on Basal Insulin Initiating Treatment With IDegLira in Routine Clinical Practice in Colombia (NCT05324462) | Novo Nordisk A/S | 2022-03-22 |
| China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE) (NCT05221580) | Novo Nordisk A/S | 2022-03-18 |
| French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome (NCT05308927) | Novo Nordisk A/S | 2022-03-16 |
| Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland (NCT05232786) | Novo Nordisk A/S | 2022-03-08 |
| A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump (NCT05262595) | Novo Nordisk A/S | 2022-03-03 |
| A Research Study of How NNC0174-0833 Behaves in Chinese Volunteers Who Are Normal Weight, Overweight or With Obesity (NCT05254158) | Novo Nordisk A/S | 2022-03-03 |
| A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity (NCT05236517) | Novo Nordisk A/S | 2022-02-08 |
| A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People (NCT05227196) | Novo Nordisk A/S | 2022-02-04 |
| Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya® (NCT05230550) | Novo Nordisk A/S | 2022-02-03 |
| A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide (NCT05232708) | Novo Nordisk A/S | 2022-01-19 |
| Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy (NCT05243823) | Novo Nordisk A/S | 2022-01-15 |
| A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation of Blood Clots. (NCT05178550) | Novo Nordisk A/S | 2021-12-17 |
| A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause (NCT05153564) | Novo Nordisk A/S | 2021-12-13 |
| A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants (NCT05091073) | Novo Nordisk A/S | 2021-12-09 |
| A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland (NCT05153590) | Novo Nordisk A/S | 2021-12-03 |
| A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors (NCT05053139) | Novo Nordisk A/S | 2021-12-02 |
| A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works (NCT05134987) | Novo Nordisk A/S | 2021-12-01 |